This company seems to have been delisted
Reason: Filed for chapter 7 bankruptcy
Last recorded trade on: December 27, 2023
Source: https://www.genomeweb.com/business-news/biocept-files-chapter-7-bankruptcy
Reason: Filed for chapter 7 bankruptcy
Last recorded trade on: December 27, 2023
Source: https://www.genomeweb.com/business-news/biocept-files-chapter-7-bankruptcy
Biocept
BIOC
$0.62
Share price
0.00%
Change (1 day)
-95.52%
Change (1 year)
Categories
Revenue for Biocept (BIOC)
Revenue in 2023 (TTM): -C$4.63 Million
According to Biocept
's latest financial reports the company's current revenue (TTM 
) is -C$4.89 Million. In 2022 the company made a revenue of C$35.08 Million a decrease over the revenue in the year 2021 that were of C$78.05 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Biocept from 2013 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | -C$4.63 Million | -113.18% |
| 2022 | C$35.08 M | -55.05% |
| 2021 | C$78.05 M | 122.93% |
| 2020 | C$35.01 M | 384.93% |
| 2019 | C$7.22 M | 63.08% |
| 2018 | C$4.42 M | -30.52% |
| 2017 | C$6.37 M | 47.13% |
| 2016 | C$4.33 M | 411.94% |
| 2015 | C$0.84 M | 446.46% |
| 2014 | C$0.15 M | 8.34% |
| 2013 | C$0.14 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | C$3.92 B | -80,392.99% | 🇺🇸 USA |
 | C$1.19 B | -24,477.18% | 🇺🇸 USA |
 | C$0.63 B | -13,073.34% | 🇺🇸 USA |